Schwazze CEO Krishnamurthy resigns; CFO Hoffmaster named interim CEO

Medicine Man Technologies, Inc.

CEO Nirup Krishnamurthy resigned Feb 20, 2024 for personal reasons; no disagreement.
Separation agreement: 8 months severance at current base salary plus COBRA coverage.
CFO Forrest Hoffmaster appointed interim CEO effective Feb 21, 2024.
Hoffmaster's base salary increased from $360k to $400k; eligible for $240k bonus in 6 months.
Board to search for permanent CEO and a replacement director following Krishnamurthy's departure.

item 1.01 item 5.02 item 1.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Forrest Hoffmaster

interim Chief Executive Officer

Medicine Man Technologies, Inc.

Effective: 2024-02-21
Filed: February 23, 2024, 6:59 PM ET

On February 21, 2024 (“Appointment Date”), the Board appointed Forrest Hoffmaster, the Company’s Chief Financial Officer, as interim Chief Executive Officer of the Company.

Departed

Nirup Krishnamurthy

Chief Executive Officer

Medicine Man Technologies, Inc.

Effective: 2024-02-20
Successor: Forrest Hoffmaster
Filed: February 23, 2024, 6:59 PM ET

On February 20, 2024, the Company received notice of the resignation of Nirup Krishnamurthy as a member of the Company’s board of directors (the “Board”) and Chief Executive Officer of the Company

Departed

Nirup Krishnamurthy

Director

Medicine Man Technologies, Inc.

Effective: 2024-02-20
Filed: February 23, 2024, 6:59 PM ET

resignation of Nirup Krishnamurthy as a member of the Company’s board of directors

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Forrest Hoffmaster was appointed as interim Chief Executive Officer at Medicine Man Technologies, Inc..

Action: appointed
Role: interim Chief Executive Officer

Exact text from the filing

On February 21, 2024 (“Appointment Date”), the Board appointed Forrest Hoffmaster, the Company’s Chief Financial Officer, as interim Chief Executive Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Nirup Krishnamurthy resigned as Chief Executive Officer at Medicine Man Technologies, Inc..

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

On February 20, 2024, the Company received notice of the resignation of Nirup Krishnamurthy as a member of the Company’s board of directors (the “Board”) and Chief Executive Officer of the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Nirup Krishnamurthy resigned as Director at Medicine Man Technologies, Inc..

Action: resigned
Role: Director

Exact text from the filing

resignation of Nirup Krishnamurthy as a member of the Company’s board of directors

View on SEC.gov

Source: SEC EDGAR

accession 0001104659-24-026820

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.